Industry: Pharmaceuticals, Biotechnology
HoustonPharma is a privately held biopharmaceutical company located in Houston, Texas that is developing oncolytic virus technologies for the treatment of cancer, including ovarian cancer, glioblastoma and multiple myeloma. HoustonPharma’s most advanced products are in Phase I clinical trials. Potomac Pharma, our wholly owned subsidiary, is developing new treatments for mental illness based on alpha-2 receptor antagonism. The first application is Schizophrenia where the company’s lead compound, Idazoxan, is in Phase IIb clinical development. ( www.houstonpharma.com )
6750 West Loop South Suite 790
Bellaire, Texas 77401
USA
Tel: (713) 662-3338
Fax: (800) 861-1175